Company Filing History:
Years Active: 2021-2025
Title: Jean Ducassou - Innovator in Pharmaceutical Formulations.
Introduction
Jean Ducassou is a notable inventor in the field of pharmaceuticals. He has contributed to the development of innovative formulations that combine effective medications. His work focuses on improving treatment options for patients through fixed-dose combinations.
Latest Patents
Jean Ducassou holds a patent for a formulation titled "Eflornithine And Sulindac, Fixed Dose Combination Formulation." This patent provides a detailed description of fixed-dose combination formulations that include a pharmaceutically effective amount of eflornithine along with sulindac. The patent also outlines methods of use and manufacturing processes for these formulations.
Career Highlights
Throughout his career, Ducassou has demonstrated a commitment to advancing pharmaceutical science. His innovative approach to drug formulation has the potential to enhance patient care and treatment efficacy. Although he currently holds no patents, his contributions to the field are significant.
Collaborations
Ducassou has collaborated with Patrick Shannon, a fellow innovator in the pharmaceutical industry. Their partnership has focused on developing effective drug combinations that can improve therapeutic outcomes for patients.
Conclusion
Jean Ducassou's work in pharmaceutical formulations showcases his dedication to innovation in medicine. His contributions, particularly in fixed-dose combinations, highlight the importance of collaboration and creativity in advancing healthcare solutions.